Citi Pharma Limited aur Hangzhou Newsea Technology Co., Ltd ke darmiyan Joint Venture karne ka fesla.
Citi Pharma Limited ne Hangzhou Newsea Technology Co., Ltd ke sath Joint Venture shuru kiya hai. Is JV ka maqsad Citi Pharma Limited ki API’s tayar karna hai. Is step ka irada unki product range ko barhana hai.
Citi Pharma Limited ab tak 20 se 22 APIs tayar karti hai. Lekin, healthcare landscape ki tabdeeli aur mukhtalif pharmaceutical products ki barhti hui darkhwast ko dekhte hue, company ne apni product range ko barhane ka faisla kiya hai. Is JV ke zariye, wo 30 aur APIs tayar karna chahti hai.
Is Joint Venture ka maqsad sustainable growth aur technology transfer ko promot karna hai Pakistan mein.
ETACI LIMITED ke zariye, Citi Pharma Limited apni API’s ki local manufacturing ko barha kar import bills mein kami aur supply chain ko behtar banane ka irada rakhti hai.
